Planned sales, announced before they happen
1 trading plan running, 1 Form 144 notice for $944K
Plans running now
1
Mr. Jeffrey Goldstein
What FIS's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Trading plans
Plans adopted or ended
| Insider | What | Date | Shares | Runs to | Reported in |
|---|---|---|---|---|---|
| Mr. Jeffrey Goldstein Independent Chair of the Company’s Board of Directors |
Adopted 10b5-1 plan | Dec 3, 2025 | up to 225,000 | Jan 22, 2027 | 10-K Feb 24, 2026 |
What the company wroteDuring the quarter ended December 31, 2025, Mr. Jeffrey Goldstein, Independent Chair of the Company’s Board of Directors, adopted a trading plan intended to satisfy the affirmative defense of Rule 10b5-1(c). Under the plan, which was adopted on December 3, 2025, Mr. Goldstein instructed his broker to purchase shares of FIS common stock each quarter in an amount approximately equal to his cash director fees, which are paid quarterly in equal installments. The aggregate purchase price for shares to be purchased under the plan is $225,000. The trading plan will expire on the earlier of January 22, 2027 or the date on which all purchases under the plan have been completed. Mr. Goldstein has informed the Company that he intends to continue to use the full amount of his cash director fees to purchase FIS common stock for so long as he remains a Director of the Company. | |||||
| Ms. Caroline Tsai Chief Legal & Corporate Affairs Officer and Corporate Secretary |
Adopted 10b5-1 plan | May 29, 2025 | up to 500,000 | May 29, 2026 | 10-Q Aug 5, 2025 |
| Mr. Jeffrey Goldstein Independent Chair of the Company’s Board of Directors |
Adopted 10b5-1 plan | Nov 18, 2024 | up to 241,000 | 438 days | 10-K Feb 13, 2025 |
What the company wroteDuring the quarter ended December 31, 2024, Mr. Jeffrey Goldstein, Independent Chair of the Company’s Board of Directors, adopted a trading plan intended to satisfy the affirmative defense of Rule 10b5-1(c). Under the plan, which was adopted on November 18, 2024, Mr. Goldstein instructed his broker to purchase shares of FIS common stock each quarter in an amount approximately equal to his cash director fees, which are paid quarterly in equal installments. The aggregate purchase price for shares to be purchased under the plan is $241,000. The trading plan will expire on the earlier of January 30, 2026 or the date on which all purchases under the plan have been completed. Mr. Goldstein has informed the Company that he intends to continue to use the full amount of his cash director fees to purchase FIS common stock for so long as he remains a Director of the Company. | |||||
| Ms. Denise Williams executive officer of the Company (Chief People Officer) |
Adopted 10b5-1 plan | Aug 14, 2024 | up to 12,484 | Mar 31, 2025 | 10-Q Nov 4, 2024 |
What the company wroteDuring the quarter ended September 30, 2024, Ms. Denise Williams, an executive officer of the Company (Chief People Officer), adopted a trading plan (the “Plan”) intended to satisfy the affirmative defense of Rule 10b5-1(c). The Plan, which was adopted on August 14, 2024, provides for the sale of up to $1,000,000 of shares of FIS common stock and up to 12,484 shares of FIS common stock to be acquired through the exercise of vested stock options. The Plan will expire on the earlier of March 31, 2025, or the date on which all sales under the Plan have been completed. | |||||
| Mr. Jeffrey Goldstein Independent Chair of the Company’s Board of Directors |
Adopted 10b5-1 plan | Nov 16, 2023 | up to 220,000 | 442 days | 10-K Feb 26, 2024 |
What the company wroteDuring the quarter ended December 31, 2023, Mr. Jeffrey Goldstein, Independent Chair of the Company’s Board of Directors, adopted a trading plan intended to satisfy the affirmative defense of Rule 10b5-1(c). Under the plan, which was adopted on November 16, 2023, Mr. Goldstein instructed his broker to purchase shares of FIS common stock each quarter in an amount approximately equal to his cash director fees, which are paid quarterly in equal installments. The aggregate purchase price for shares to be purchased under the plan is $220,000. The trading plan will expire on the earlier of January 31, 2025 or the date on which all purchases under the plan have been completed. Mr. Goldstein has informed the Company that he intends to continue to use the full amount of his cash director fees to purchase FIS common stock for so long as he remains a Director of the Company. | |||||
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 2, 2023.
Form 144
Notices of planned sales
| Filed | Seller | Shares | Value | Shares came from | 10b5-1 plan | Form 4 sales after |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | Tsai Caroline Former Officer |
22,142 | $944K | Restricted Stock Vesting | none given | none found |
From the Form 144 XML filed with the SEC, since Aug 11, 2026. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.